<bill session="118" type="s" number="113" updated="2025-07-21T19:32:26Z">
  <state datetime="2023-02-09">REPORTED</state>
  <status>
    <unknown datetime="2023-02-09"/>
  </status>
  <introduced datetime="2023-01-26"/>
  <titles>
    <title type="display">Prescription Pricing for the People Act of 2023</title>
    <title type="official" as="introduced">A bill to require the Federal Trade Commission to study the role of intermediaries in the pharmaceutical supply chain and provide Congress with appropriate policy recommendations, and for other purposes.</title>
    <title type="short" as="reported to senate">Prescription Pricing for the People Act of 2023</title>
    <title type="short" as="introduced">Prescription Pricing for the People Act of 2023</title>
  </titles>
  <sponsor bioguide_id="G000386"/>
  <cosponsors>
    <cosponsor bioguide_id="B001243" joined="2023-01-26"/>
    <cosponsor bioguide_id="B001277" joined="2023-01-26"/>
    <cosponsor bioguide_id="B001236" joined="2023-01-30"/>
    <cosponsor bioguide_id="B001310" joined="2023-01-26"/>
    <cosponsor bioguide_id="B001305" joined="2023-04-19"/>
    <cosponsor bioguide_id="C000127" joined="2023-01-26"/>
    <cosponsor bioguide_id="C001047" joined="2023-01-26"/>
    <cosponsor bioguide_id="C001070" joined="2023-03-16"/>
    <cosponsor bioguide_id="C001035" joined="2023-11-09"/>
    <cosponsor bioguide_id="C001088" joined="2023-02-07"/>
    <cosponsor bioguide_id="F000062" joined="2023-02-09"/>
    <cosponsor bioguide_id="H001042" joined="2023-02-09"/>
    <cosponsor bioguide_id="L000575" joined="2023-01-26"/>
    <cosponsor bioguide_id="M001198" joined="2023-03-29"/>
    <cosponsor bioguide_id="R000608" joined="2023-09-27"/>
    <cosponsor bioguide_id="S001181" joined="2023-11-09"/>
    <cosponsor bioguide_id="S001191" joined="2023-03-21"/>
    <cosponsor bioguide_id="T000476" joined="2023-01-26"/>
    <cosponsor bioguide_id="T000278" joined="2023-01-26"/>
    <cosponsor bioguide_id="W000790" joined="2024-07-10"/>
    <cosponsor bioguide_id="W000800" joined="2023-02-07"/>
  </cosponsors>
  <actions>
    <action datetime="2023-01-26">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2023-01-26" state="REFERRED">
      <text>Read twice and referred to the Committee on the Judiciary.</text>
    </action>
    <action datetime="2023-02-09" state="REPORTED">
      <text>Committee on the Judiciary. Ordered to be reported with an amendment in the nature of a substitute favorably.</text>
    </action>
    <action datetime="2023-03-01">
      <text>Committee on the Judiciary. Reported by Senator Durbin with an amendment in the nature of a substitute. Without written report.</text>
    </action>
    <calendar datetime="2023-03-01" calendar="Senate Legislative" under="General Orders" number="19">
      <text>Placed on Senate Legislative Calendar under General Orders. Calendar No. 19.</text>
    </calendar>
  </actions>
  <committees>
    <committee code="SSJU" name="Senate Judiciary" subcommittee="" activity="Reported By, Markup By, Referred To"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Commerce"/>
    <term name="Business ethics"/>
    <term name="Business records"/>
    <term name="Competition and antitrust"/>
    <term name="Congressional oversight"/>
    <term name="Consumer affairs"/>
    <term name="Health care costs and insurance"/>
    <term name="Health information and medical records"/>
    <term name="Inflation and prices"/>
    <term name="Prescription drugs"/>
    <term name="Retail and wholesale trades"/>
  </subjects>
  <amendments/>
  <summary date="2023-03-21T14:58:50Z" status="Reported to Senate">Prescription Pricing for the People Act of 2023This bill requires the Federal Trade Commission (FTC) to report about anticompetitive practices and other trends within the pharmaceutical supply chain that may impact the cost of prescription drugs. The FTC also must provide recommendations to increase transparency in the supply chain and prevent anticompetitive practices.</summary>
</bill>
